CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Vareniclinedrug
Likely dose
Varenicline 1 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01378858
NCT01378858N/ACompleted
CompareCT.gov

Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients

Albert Einstein College of Medicine·interventional·Posted Jun 23, 2011·Updated Mar 11, 2021

In Brief

A clinical study evaluating Varenicline for Tobacco Use Disorder and Medication Adherence. Completed, enrolled 100 participants across 1 site.

Detailed Summary

This randomized trial will evaluate whether varenicline directly observed therapy provided at a methadone clinic is more efficacious than self-administered varenicline for promoting smoking cessation and enhancing adherence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTobacco Use Disorder, Medication Adherence
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJun 23, 2011
Enrollment StartJul 1, 2011
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 15.0 years ago

Interventions

Vareniclinedrug

Varenicline, titrated to 1 mg twice daily, will be given to participants in both study arms for 12 weeks.